Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Ouathek Ouerfelli is a pioneering figure in the field of fluorescence-guided surgery, with a focused expertise in developing novel contrast agents to enhance intraoperative visualization. His most significant contribution centers on the preclinical and clinical translation of Rizedisben, a myelin-binding fluorophore designed to improve the real-time identification of peripheral nerves during minimally invasive procedures. By fluorescing in the blue light spectrum (370-425 nm), Rizedisben addresses a critical unmet need in surgery: the prevention of iatrogenic nerve damage. Dr. Ouerfelli’s work, including his landmark 2025 study, has been instrumental in determining the optimal safe dosing and imaging parameters for this agent, demonstrating its potential to reduce complications in complex surgeries. While his citation count is currently emerging, the novelty and direct clinical applicability of his research position him as a key innovator in surgical oncology and neuroprotection. His achievements represent a significant step toward making "invisible" anatomy visible, promising to redefine standards of care in operative safety.